Summary
Variation in the systemic disposition of theophylline after ingestion of a new microcrystalline product (Theolair®) has been investigated in 7 hospitalized patients with generalized obstructive lung disease. Disposition (absolute bioavailability) was determined by comparing in the same patients the areas under the serum concentration-time curves after a single oral dose of microcrystalline theophylline and after an intravenous infusion of aminophylline. Oral absorption appeared to be fast. The half-life of absorption was 19±9 min (mean±SD). Maximal serum concentrations reached after 100±30 min were found to be in a rather narrow range: 9.8±2.5 mg · 1−1. The absolute bioavailability of the microcrystalline preparation was high and it showed only small variation: 102.7±10.2% of the dose. Relevant pharmacokinetic parameters (half-life of elimination, volume of distribution and total body clearance) were determined after both routes of administration. Individual dosage regimens required to obtain a therapeutic serum concentration were calculated for each individual patient on the basis of the observed pharmacokinetic parameters.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Berg WC, Jonkman JHG, De Vries K, Orie NGM (1979) A multidose comparative study of microcrystalline theophylline and a choline theophyllinate. Curr Med Res Opin, Suppl 6: 64–70
Cohen A, Johnson C, Osvaldo R (1975) A rapid dissolving theophylline tablet. Curr Ther Res 17: 497–505
De Blaey CJ, Rutten-Kingma JJ (1977) Biopharmaceutics of aminophylline suppositories II, In Vitro release rate during storage. Pharm Acta Helv 52: 11–14
Elwood RK, Kelly JG, McDevitt DG (1978) Pharmacokinetics of a microcrystalline theophylline preparation in patients with chronic obstructive airways disease. Eur J Clin Pharmacol 13: 29–33
Graham G, Hartnett BS, Hayter R (1974) Rapidly dissolving tablets of theophylline. Aust J Pharm Sci 13: 66–68
Hartnett BJS, Marlin GE, Graham G (1974) Clinical trial of rapidly dissolving theophylline tablets. Med J Aust 1: 532–535
Hendeles L, Bighley L, Richardson RH, Hepler CD, Carmichael J (1977) Frequent toxicity from I. V. aminophylline infusions in critically ill patients. Drug Intell Clin Pharm 11: 12–18
Hendeles L, Weinberger M, Bighley L (1978) Disposition of theophylline after a single intravenous infusion of aminophylline. Am Rev Respir Dis 118: 97–103
Holley RA, Mildon CA, French IW (1978) Single- and multi-dose bioavailability study of a new rapidly dissolving theophylline tablet. Curr Ther Res 23: 330–344
Hunt SN, Jusko WJ, Yurchak AM (1976) Effect of smoking on theophylline disposition. Clin Pharmacol Ther 19: 546–551
Jacobs MH, Senior RM, Kessler G (1976) Clinical experience with theophylline: relationship between dosage, serum concentration and toxicity. J Am Med Assoc 235: 1983–1986
Jenne JW, Wyze E, Rood FS, MacDonald FM (1972) Pharmacokinetics of theophylline: application to adjustment of the clinical dose of aminophylline. Clin Pharmacol Ther 13: 349–360
Jenne J, Nagasawa H, McHugh R, MacDonald F, Wyse E (1975) Decreased theophylline half-life in cigarette smokers. Life Sci 17: 195–197
Jonkman JHG, Schoenmaker R, Greving JE, De Zeeuw RA (1980) Rapid and selective theophylline serum and saliva assay by means of high pressure liquid chromatography. Pharm Weekbl Sci Ed 2: 49–53
Levy G, Koysooko R (1975) Pharmacokinetic analysis of the effect of theophylline on pulmonary function in asthmatic children. J Ped 86: 789–793
Lillehei JP (1968) Aminophylline oral v. s. rectal administrations. J Am Med Assoc 205: 530–533
Mitenko PA, Ogilvie RI (1973) Rational intravenous doses of theophylline. N Engl J Med 289: 600–603
Piafsky KM, Ogilvie RI (1975) Dosage of theophylline in bronchial asthma. N Engl J Med 292: 1218–1222
Powell JR, Thiercelin J-F, Vozeh S, Sansom L, Reigelman S (1977) The influence of cigarette smoking and sex on theophylline disposition. Am Rev Respir Dis 116: 17–23
Powell JR, Vozeh S, Hopewell P, Costello J, Sheiner LB, Riegelman S (1978) Theophylline disposition in acutely ill hospitalized patients; the effect of smoking, heart failure, severe airway obstruction and pneumonia. Am Rev Respir Dis 118: 229–238
Ritschel WA (1976) Handbook of Basic Pharmacokinetics. Drug Inteligence-Publications, Hamilton
Sheiner LB, Tozer TN (1978) Clinical Pharmacokinetics: the use of plasma concentrations of drugs. In: Melmon KL, Morelli HF (eds) Clinical pharmacology. MacMillan, New York
Turner-Warwick M (1957) Study of theophylline plasma levels after oral administration of new theophylline compounds. Br Med J 2: 67–69
Weinberger MW, Reigelman S (1974) Rational use of theophylline for bronchodilation. N Engl J Med 291: 151–153
Weinberger MW, Matthay RA, Ginchansky EJ, Chidsey CA, Petty TL (1976) Intravenous aminophylline dosage: use of serum theophylline measurement for guidance. J Am Med Assoc 235: 2110–2113
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jonkman, J.H.G., Berg, W.C., Schoenmaker, R. et al. Disposition and clinical pharmacokinetics of microcrystalline theophylline. Eur J Clin Pharmacol 17, 379–384 (1980). https://doi.org/10.1007/BF00558452
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00558452